Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Class A Ordinary Shares, $0.0001 par value per share
-
Shares outstanding
-
14,778,366,141
-
Total 13F shares
-
821,611
-
Share change
-
-1,790,656
-
Total reported value
-
$468,070
-
Price per share
-
$0.57
-
Number of holders
-
26
-
Value change
-
-$1,586,794
-
Number of buys
-
8
-
Number of sells
-
12
Institutional Holders of TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0001 par value per share (TRIB) as of Q1 2025
As of 31 Mar 2025,
TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0001 par value per share (TRIB) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
821,611 shares.
The largest 10 holders included
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, Whitefort Capital Management, LP, RENAISSANCE TECHNOLOGIES LLC, HRT FINANCIAL LP, CITADEL ADVISORS LLC, Moss Adams Wealth Advisors LLC, RAYMOND JAMES FINANCIAL INC, Cambridge Investment Research Advisors, Inc., Williams & Novak, LLC, and BECKER CAPITAL MANAGEMENT INC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.